JP2013536206A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536206A5
JP2013536206A5 JP2013525143A JP2013525143A JP2013536206A5 JP 2013536206 A5 JP2013536206 A5 JP 2013536206A5 JP 2013525143 A JP2013525143 A JP 2013525143A JP 2013525143 A JP2013525143 A JP 2013525143A JP 2013536206 A5 JP2013536206 A5 JP 2013536206A5
Authority
JP
Japan
Prior art keywords
patient
pharmaceutically acceptable
phenyl
dimethyl
phenylsulfanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013525143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013536206A (ja
JP5902169B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2011/050317 external-priority patent/WO2012025123A1/en
Publication of JP2013536206A publication Critical patent/JP2013536206A/ja
Publication of JP2013536206A5 publication Critical patent/JP2013536206A5/ja
Application granted granted Critical
Publication of JP5902169B2 publication Critical patent/JP5902169B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013525143A 2010-08-23 2011-08-22 1−[2−(2,4−ジメチル−フェニルスルファニル)フェニル]ピペラジンの治療的使用 Active JP5902169B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37588510P 2010-08-23 2010-08-23
DKPA201000739 2010-08-23
US61/375,885 2010-08-23
DKPA201000739 2010-08-23
PCT/DK2011/050317 WO2012025123A1 (en) 2010-08-23 2011-08-22 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine

Publications (3)

Publication Number Publication Date
JP2013536206A JP2013536206A (ja) 2013-09-19
JP2013536206A5 true JP2013536206A5 (https=) 2014-10-09
JP5902169B2 JP5902169B2 (ja) 2016-04-13

Family

ID=44532506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013525143A Active JP5902169B2 (ja) 2010-08-23 2011-08-22 1−[2−(2,4−ジメチル−フェニルスルファニル)フェニル]ピペラジンの治療的使用

Country Status (32)

Country Link
US (5) US20130184291A1 (https=)
EP (1) EP2608789B2 (https=)
JP (1) JP5902169B2 (https=)
KR (1) KR101816953B1 (https=)
CN (1) CN103068389A (https=)
AP (1) AP3583A (https=)
AR (1) AR082501A1 (https=)
AU (1) AU2011295465B8 (https=)
BR (2) BR122020025600A2 (https=)
CA (1) CA2807062C (https=)
CL (1) CL2013000492A1 (https=)
CO (1) CO6680652A2 (https=)
CY (1) CY1118886T1 (https=)
DK (1) DK2608789T4 (https=)
ES (1) ES2625142T5 (https=)
FI (1) FI2608789T4 (https=)
HR (1) HRP20170608T4 (https=)
HU (1) HUE034155T2 (https=)
IL (1) IL224371A (https=)
LT (1) LT2608789T (https=)
ME (1) ME02674B (https=)
MX (1) MX349724B (https=)
PL (1) PL2608789T5 (https=)
PT (1) PT2608789T (https=)
RS (1) RS55851B2 (https=)
RU (1) RU2564666C2 (https=)
SG (1) SG187649A1 (https=)
SI (1) SI2608789T2 (https=)
SM (1) SMT201700239T1 (https=)
TW (1) TW201212918A (https=)
WO (1) WO2012025123A1 (https=)
ZA (1) ZA201301385B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106103418A (zh) 2014-01-31 2016-11-09 埃吉斯药物私人有限公司 沃替西汀盐的制备方法
CN104119299B (zh) * 2014-08-13 2016-08-17 北京蓝贝望生物医药科技股份有限公司 沃赛汀或沃替西汀的氢溴酸盐
CN104119298B (zh) * 2014-08-13 2016-08-24 北京蓝贝望生物医药科技股份有限公司 氢溴酸沃赛汀或氢溴酸沃替西汀
CN104610195B (zh) * 2015-01-30 2017-06-27 上虞京新药业有限公司 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途
WO2018002115A1 (en) 2016-07-01 2018-01-04 H. Lundbeck A/S Vortioxetine dosing regimes for fast onset of antidepressant effect
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DK0543584T3 (da) * 1991-11-18 1996-07-01 Lilly Industries Ltd Benzo(b)thiophen-2-carboxamider til behandling af forstyrrelser i centralnervesystemet
US20080103179A1 (en) * 2006-10-27 2008-05-01 Tam Peter Y Combination Therapy
EP2090769A1 (en) 2000-10-02 2009-08-19 Rohr, Inc. Apparatus, method and system for gas turbine engine noise reduction
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
PL2044043T5 (pl) * 2006-06-16 2022-05-02 H. Lundbeck A/S Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych
TW200848411A (en) 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW200932233A (en) * 2007-11-13 2009-08-01 Lundbeck & Co As H Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity

Similar Documents

Publication Publication Date Title
TWI776407B (zh) 激動劑形成之調配物及使用其之方法
JP4938905B2 (ja) 選択的s1p1レセプターアゴニストの投与法
JP6891385B2 (ja) トラジピタントによる治療方法
JP2014517050A5 (https=)
JP2017528507A5 (https=)
JP7436524B2 (ja) ハンチントン病及びその症状を治療するためのプリドピジン及びその類似体を含む組成物
JP2013536206A5 (https=)
Papakostas et al. A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder
CA3083341C (en) Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
JP2019515909A5 (https=)
CN105764510A (zh) H3受体拮抗剂与胆碱酶抑制剂组合用于阿尔茨海默氏病治疗中的用途
JP2018203774A (ja) 精神障害の治療における使用のためのイロペリドン代謝物
RU2013112890A (ru) Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
JP2019507786A5 (https=)
Grunberg et al. Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management: Proceedings from a symposium at the 2008 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
US9724340B2 (en) Antitussive compositions and methods
CN110573148A (zh) 特发性肺纤维化的治疗
JP2025176192A (ja) 好酸球性喘息の処置のためのmasitinibの使用
JP2012502105A5 (https=)
JP2007519646A (ja) 体重の持続的低減のための化合物
JP2021503448A5 (https=)
JP2020535139A (ja) シポニモドの投与レジメン
TWI864376B (zh) 焦慮症處置用組成物及處置方法
JP2015515971A5 (https=)
JP6734469B2 (ja) ヒスタミン−3受容体インバースアゴニスト、アセチルコリンエステラーゼ阻害剤及びnmda受容体アンタゴニストの3種組合せ